Soleus Capital Master Fund, L.P.

Holdings History for UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN)

Symbol: URGN on Nasdaq
Investment type: Equity / Ordinary Shares, par value NIS 0.01 per share
Latest Disclosed Shares Owned: 2,185,000 shares
Security Ownership %: 4.7%

Soleus Capital Master Fund, L.P. ownership in UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN)

05 Aug 2025 - Soleus Capital Master Fund, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,185,000 shares of UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN). This represents 4.7% ownership of the company. In their previous filing dated 16 Jun 2025, Soleus Capital Master Fund, L.P. had reported owning 2,325,000 shares, indicating a decrease of +6%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Soleus Capital Master Fund, L.P.	4.7%	-6%	$31,114,400	2,185,000	-140,000	-6%	$14.24	13G/A	30 Jun 2025	05 Aug 2025, 17:00
Soleus Capital Master Fund, L.P.	5%		$23,575,500	2,325,000			$10.14	13G	13 Jun 2025	16 Jun 2025, 17:00